Skip to main content
. 2022 Jan 12;23:9. doi: 10.1186/s12931-021-01895-6

Table 1.

Suggested target values for key cardiopulmonary exercise testing variables (cycle ergometry) [1, 57, 10, 11, 15]

Variable Target value Abnormal
Peak V˙O2 (exercise capacity)  ≥ 85% based on V˙O2 pred. or > 20 mL O2/min/kg  < 85%/ < 70%/ < 50% (mild/moderate/severe)
V˙O2/WR (aerobic capacity) ≥ 9–10 mL/min/watt1  ≤ 8 mL/min/watt
V˙O2 at AT  ≥ 40–80% pred. V˙O (usually 50–65% of peak V˙O2)  < 40%/ < 30%/ < 25% (mild/moderate/severe)
Blood pressure Increase by 10 mmHg per 30 watts Decrease, inadequate increase
O2 pulse (V˙O2/HR)2 ≥ 80% < 70% pred. during peak exercise
Heart rate reserve (HRR) ≥ 85% pred. (< 15 bpm) < 85% predicted (but wide range)
Breathing reserve (BR) ≥ 15–20% (or ≥ 11–15 L/min) < 15–20% (or < 11–15 L/min)
Breathing frequency (BF) ≤ 50/min ≥ 60/min
EqCO2 at AT 25–30 at AT, ≤ 40 after AT ≥ 35 at AT, > 40 after AT;
EqO2 at AT 20–30 at AT, ≤ 40 after AT ≥ 35 at AT, > 40 after AT
V˙E/V˙CO2 slope 25–30 (slightly lower than EqCO2 at AT) ≥ 35 or < 20
RER ≥ 1.05 (ill) or ≥ 1.1 (healthy); > 1.1–1.5 in recovery phase; at rest: > 0.7, < 1.0 < 1 (peak exercise)
PETCO2 (≈ PACO2 ≈ PaCO2) > 35 mmHg (at rest); > 40 mmHg (during exercise)  < 33 mmHg (at rest), < 3 mmHg increase or > 50 mmHg (peak exercise)
PETO2 (≈ PAO2)  ≥ 90 mmHg (at rest), 20–30 mmHg increase during exercise Lack of increase or decrease during exercise
P(A-a) O23 20 mmHg (at rest); 30 mmHg (during exercise) > 35 mmHg
P(a-ET) CO24 At rest: minimally positive; during exercise: slightly negative > 5 mmHg

a arterial, A alveolar, AT anaerobic threshold, bpm beats/minute, CO2 carbon dioxide, Eq ventilatory equivalent, ET end-tidal, HR heart rate, O2 oxygen, P pressure, pred. predicted, RER respiratory exchange rate, V˙E/V˙CO2 ventilatory equivalent for carbon dioxide, V˙O2 oxygen uptake, WR work rate

1Peak V˙O2 in obesity should be expressed as L/min or referenced to weight predicted

2O2 pulse (V̇O2/HR) peak exercise values vary widely by the same factors that affect normal peak V˙O2 and HR (e.g., age, body size, gender, Hb concentration, work rate, fitness level)

3P(A-a)O2 indicates efficacy of O2 uptake. PAO2 is calculated using the alveolar air formula (requires PaCO2 from blood gas analysis [BGA]), PaO2 is also determined using BGA

4P(a-ET)CO2 indicates efficacy of CO2 output to the alveoli: PACO2 is measured as PETCO2; PaCO2 is determined by BGA. P(a-ET)CO2 is slightly positive at rest due to V/Q inhomogeneities (poorly perfused upper lung areas with impaired CO2 production, PaCO2 > PACO2), and negative due to hyperventilation during exercise (PaCO2 < PACO2 [difference approximately 4 mmHg])